LSU Health New Orleans to receive patent for a noninvasive t

US Patent 11,493,515 will be issued to LSU Health New Orleans on November 8, 2022, for a noninvasive test that more accurately diagnoses a potentially fatal condition in premature infants.

Related Keywords

South Korea , China , Australia , United States , New Zealand , Canada , Hong Kong , Chosen , Rebecca Buckley , Sunyoung Kim , Carl Sabottke , Duna Penn , Patrick Reed , Emily Henderson , Health New Orleans On , Health New Orleans Assistant Vice , Human Development , Drug Administration , Trademark Office , Diagnostics Inc , Health New Orleans Schools Of Medicine , National Institute Of Child Health , New Orleans , Molecular Biology , New Orleans Schools , Graduate Studies , National Institute , Child Health , Chosen Diagnostics Inc , Express License , Faculty Startups , New Orleans Research Assistant Professor , Chosen Diagnostic Chief Operating , Zeromeh Gerber , States Patent , Orleans Parish , Breakthrough Device Designation , New Orleans Assistant Vice Chancellor , Chosen Diagnostics , Biochemistry , Biomarker , Birth Weight , Iagnostic , Iagnostics , Enterocolitis , Gastrointestinal Disease , Health Care , Hospital , Medicine , Necrotizing Enterocolitis , Neonatology , Newborn , Research ,